RNAx and Nucleis announce a collaboration to co-market in vitro and in vivo shRNA target validation technology
08-Sep-2005 -
Nucleis, a biotechnological company focused on the creation of custom made transgenic mice, and RNAx announced the signing of a non-exclusive co-marketing agreement.
Under the terms of the agreement RNAx provides Nucleis and its customers with in vitro shRNA
validation technology to complement ...
cell lines
gene expression profiling
target validation
+1